This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Everything you need to know about PT-141 (Bremelanotide) dosing — protocols, safety, and where to buy.
Dose Range
500–2,000 mcg (0.5–2 mg) per dose
Frequency
As needed, 45 minutes before sexual activity; max once per 24 hours, max 8 doses/month
Cycle Length
As needed (not a cycle-based peptide)
Half-Life
~2 hours
Calculate syringe units instantly
Syringe Draw
10.0 units
2500 mcg/ml · 0.100 ml draw
Contraindications
Uncontrolled hypertension. Cardiovascular disease. Concurrent use of PDE5 inhibitors (Viagra/Cialis) — risk of hypotension. Pregnancy or breastfeeding.
FDA-approved as Vyleesi® for premenopausal women with HSDD. Used off-label in men. Inject 45 minutes before anticipated activity. Nausea is common — consider anti-nausea medication. Do NOT use more than 8 doses per month. Avoid in uncontrolled hypertension.
Where to Buy PT-141 (Bremelanotide)
Compare 5 listings across 4 vendors — from $29.99
The typical dose range for PT-141 (Bremelanotide) is 500–2,000 mcg (0.5–2 mg) per dose. It is usually administered As needed, 45 minutes before sexual activity; max once per 24 hours, max 8 doses/month. Always start with the lowest effective dose.
As needed, 45 minutes before sexual activity; max once per 24 hours, max 8 doses/month
Yes, typical cycle length is As needed (not a cycle-based peptide).
Nausea, flushing, headache. Rare: transient increases in blood pressure, nasal congestion. Women may experience increased vaginal lubrication.
Compare 5 listings from 4 vendors on our price comparison page — starting from $29.99.
PT-141 (Bremelanotide) Full Profile
Research data, mechanisms, and pricing
Interaction Checker
Check drug & compound interactions